nedaplatin has been researched along with ampelopsin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, L; Li, M; Liang, J; Liu, B; Liu, J; Lu, C; Ma, S; Ren, H; Zhang, Q; Zhu, R | 1 |
1 other study(ies) available for nedaplatin and ampelopsin
Article | Year |
---|---|
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Flavonols; Humans; Liver Neoplasms; Organoplatinum Compounds; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2015 |